fbpx
November 5, 2025

Glowface – 11/03/2025

Product: Drugs Recipient: Glowface United States Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices United States WARNING LETTER November 3, […]
November 5, 2025

Derma Solution – 11/03/2025

Product: Drugs Recipient: Derma Solution United States Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices United States WARNING LETTER November […]
November 5, 2025

MJS Medicals – 11/03/2025

Product: Drugs Recipient: MJS Medicals South Korea Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices United States WARNING LETTER November […]
November 5, 2025

Meamo – 11/03/2025

Product: Drugs Recipient: Meamo South Korea Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices United States WARNING LETTER November 3, […]
November 5, 2025

Glam Derma – 11/03/2025

Product: Drugs Recipient: Glam Derma Netherlands Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices United States WARNING LETTER November 3, […]
November 5, 2025

COSMO KOREA – 11/03/2025

Product: Drugs Recipient: COSMO KOREA South Korea Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices United States WARNING LETTER November […]
November 5, 2025

CelestaPro – 718613 – 11/03/2025

Product: Drugs Recipient: CelestaPro United States Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices United States WARNING LETTER November 3, […]
November 5, 2025

Estaderma – 718714 – 11/03/2025

Product: Drugs Recipient: Estaderma South Korea Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices United States WARNING LETTER November 3, […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0